First new 'quit-smoking' drug in 20 years shows promising results in US trial: ‘Hope and excitement’

Achieve Life Sciences, Inc., a Seattle, Washington-based pharmaceutical company, has announced positive results from the Phase 3 trial of a smoking cessation drug called cytisinicline.